Log in to save to my catalogue

Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432597

Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

About this item

Full title

Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2020-07, Vol.21 (15), p.5407

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Although celiac disease (CD) is an autoimmune disease that primarily involves the intestinal tract, mounting evidence suggests that a sizeable number of patients exhibit neurological deficits. About 40% of the celiac patients with neurological manifestations have circulating antibodies against neural tissue transglutaminase-6 (tTG6). While early di...

Alternative Titles

Full title

Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432597

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7432597

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms21155407

How to access this item